Back to Search
ALBERTO MARCELIN, MD
MD
Family Medicine Physician
NPI: 1669769485IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
56986(MN)30292(NE)
Education
OTHER
Class of 2011
Research & Publications (20)
Genotypic resistance analysis of the virological response to fosamprenavir-ritonavir in protease inhibitor-experienced patients in CONTEXT and TRIAD clinical trials.
PMID 18852278·Antimicrob Agents Chemother·2008
3-trial
Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma.
PMID 18670231·AIDS·2008
8-other
Tipranavir-ritonavir genotypic resistance score in protease inhibitor-experienced patients.
PMID 18625773·Antimicrob Agents Chemother·2008
8-other
KSHV after an organ transplant: should we screen?
PMID 17089800·Curr Top Microbiol Immunol·2007
6-review
Relationship between the quantity of Kaposi sarcoma-associated herpesvirus (KSHV) in peripheral blood and effusion fluid samples and KSHV-associated disease.
PMID 17955434·J Infect Dis·2007
8-other
Clinical validation of saquinavir/ritonavir genotypic resistance score in protease-inhibitor-experienced patients.
PMID 17503666·Antivir Ther·2007
4-observational
[Resistance to protease inhibitors: the burden of mutations].
PMID 17075997·Med Mal Infect·2006
6-review
Impact of HIV-1 reverse transcriptase polymorphism at codons 211 and 228 on virological response to didanosine.
PMID 17310813·Antivir Ther·2006
4-observational
Virological and pharmacological parameters predicting the response to lopinavir-ritonavir in heavily protease inhibitor-experienced patients.
PMID 15855487·Antimicrob Agents Chemother·2005
3-trial
Clinically relevant genotype interpretation of resistance to didanosine.
PMID 15855490·Antimicrob Agents Chemother·2005
3-trial
Resistance profiles observed in virological failures after 24 weeks of amprenavir/ritonavir containing regimen in protease inhibitor experienced patients.
PMID 15258963·J Med Virol·2004
8-other
Clinically relevant interpretation of genotype and relationship to plasma drug concentrations for resistance to saquinavir-ritonavir in human immunodeficiency virus type 1 protease inhibitor-experienced patients.
PMID 15561845·Antimicrob Agents Chemother·2004
8-other
Fatal disseminated Kaposi's sarcoma following human herpesvirus 8 primary infections in liver-transplant recipients.
PMID 14762870·Liver Transpl·2004
5-case
Antiretroviral combinations implicated in emergence of the L74I and L74V resistance mutations in HIV-1-infected patients.
PMID 19050391·AIDS·2009
8-other
The G140S mutation in HIV integrases from raltegravir-resistant patients rescues catalytic defect due to the resistance Q148H mutation.
PMID 19129221·Nucleic Acids Res·2009
8-other
Mutations associated with virological response to darunavir/ritonavir in HIV-1-infected protease inhibitor-experienced patients.
PMID 19147519·J Antimicrob Chemother·2009
8-other
Impact of discrepancies between the Abbott realtime and cobas TaqMan assays for quantification of human immunodeficiency virus type 1 group M non-B subtypes.
PMID 19297599·J Clin Microbiol·2009
4-observational
Genetic barriers for integrase inhibitor drug resistance in HIV type-1 B and CRF02_AG subtypes.
PMID 19320246·Antivir Ther·2009
8-other
Quasispecies variant dynamics during emergence of resistance to raltegravir in HIV-1-infected patients.
PMID 19221102·J Antimicrob Chemother·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 8343 S 168TH AVE
OMAHA, NE 68136 - Phone
- (402) 559-0444
Quick Facts
- NPI
- 1669769485
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 15
- Publications
- 20
Are you this provider?
Claim Your Profile